Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future ...